Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Prognostic significance of IMMT expression in surgically-resected lung adenocarcinoma.

Hiyoshi Y, Sato Y, Ichinoe M, Nagashio R, Hagiuda D, Kobayashi M, Kusuhara S, Igawa S, Shiomi K, Goshima N, Murakumo Y, Saegusa M, Satoh Y, Masuda N, Naoki K.

Thorac Cancer. 2019 Nov;10(11):2142-2151. doi: 10.1111/1759-7714.13200. Epub 2019 Oct 3.

2.

CD109: a multifunctional GPI-anchored protein with key roles in tumor progression and physiological homeostasis.

Mii S, Enomoto A, Shiraki Y, Taki T, Murakumo Y, Takahashi M.

Pathol Int. 2019 May;69(5):249-259. doi: 10.1111/pin.12798. Epub 2019 Jun 20. Review.

PMID:
31219232
3.

Clinicopathological and prognostic significance of nuclear UGDH localization in lung adenocarcinoma.

Hagiuda D, Nagashio R, Ichinoe M, Tsuchiya B, Igawa S, Naoki K, Satoh Y, Murakumo Y, Saegusa M, Sato Y.

Biomed Res. 2019;40(1):17-27. doi: 10.2220/biomedres.40.17.

4.

CD109 deficiency induces osteopenia with an osteoporosis-like phenotype in vivo.

Mii S, Hoshino A, Enomoto A, Murakumo Y, Ito M, Yamaguchi A, Takahashi M.

Genes Cells. 2018 Jul;23(7):590-598. doi: 10.1111/gtc.12593. Epub 2018 May 16.

5.

Prognostic significance of G6PD expression and localization in lung adenocarcinoma.

Nagashio R, Oikawa S, Yanagita K, Hagiuda D, Kuchitsu Y, Igawa S, Naoki K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Sato Y.

Biochim Biophys Acta Proteins Proteom. 2019 Jan;1867(1):38-46. doi: 10.1016/j.bbapap.2018.05.005. Epub 2018 May 9.

PMID:
29753088
6.

Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer.

Yanagita K, Nagashio R, Jiang SX, Kuchitsu Y, Hachimura K, Ichinoe M, Igawa S, Fukuda E, Goshima N, Satoh Y, Murakumo Y, Saegusa M, Sato Y.

Am J Pathol. 2018 Jun;188(6):1328-1333. doi: 10.1016/j.ajpath.2018.03.007. Epub 2018 May 8.

PMID:
29751934
7.

CD109 and squamous cell carcinoma.

Qi R, Dong F, Liu Q, Murakumo Y, Liu J.

J Transl Med. 2018 Apr 6;16(1):88. doi: 10.1186/s12967-018-1461-3. Review.

8.

Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.

Matsumoto T, Nagashio R, Ryuge S, Igawa S, Kobayashi M, Fukuda E, Goshima N, Ichinoe M, Jiang SX, Satoh Y, Masuda N, Murakumo Y, Saegusa M, Sato Y.

Pathol Int. 2018 Apr;68(4):232-240. doi: 10.1111/pin.12646. Epub 2018 Feb 12.

PMID:
29431238
9.

Prognostic significance of S100A16 subcellular localization in lung adenocarcinoma.

Kobayashi M, Nagashio R, Saito K, Aguilar-Bonavides C, Ryuge S, Katono K, Igawa S, Tsuchiya B, Jiang SX, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Sato Y.

Hum Pathol. 2018 Apr;74:148-155. doi: 10.1016/j.humpath.2018.01.001. Epub 2018 Jan 7.

PMID:
29320753
10.

S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma.

Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N.

Onco Targets Ther. 2017 Nov 2;10:5273-5279. doi: 10.2147/OTT.S145072. eCollection 2017.

11.

Clinicopathological Significance of S100A14 Expression in Lung Adenocarcinoma.

Katono K, Sato Y, Kobayashi M, Saito K, Nagashio R, Ryuge S, Igawa S, Nakashima H, Shiomi K, Satoh Y, Ichinoe M, Murakumo Y, Saegusa M, Masuda N.

Oncol Res Treat. 2017;40(10):594-602. doi: 10.1159/000478100. Epub 2017 Sep 19.

12.

Significance of perivascular tumour cells defined by CD109 expression in progression of glioma.

Shiraki Y, Mii S, Enomoto A, Momota H, Han YP, Kato T, Ushida K, Kato A, Asai N, Murakumo Y, Aoki K, Suzuki H, Ohka F, Wakabayashi T, Todo T, Ogawa S, Natsume A, Takahashi M.

J Pathol. 2017 Dec;243(4):468-480. doi: 10.1002/path.4981. Epub 2017 Nov 1.

PMID:
28888050
13.

Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.

Ryuge S, Sato Y, Nagashio R, Hiyoshi Y, Katono K, Igawa S, Nakashima H, Shiomi K, Ichinoe M, Murakumo Y, Saegusa M, Satoh Y, Masuda N.

PLoS One. 2017 Mar 30;12(3):e0173886. doi: 10.1371/journal.pone.0173886. eCollection 2017.

14.

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.

Igawa S, Sato Y, Ryuge S, Ichinoe M, Katono K, Hiyoshi Y, Otani S, Nagashio R, Nakashima H, Katagiri M, Sasaki J, Murakumo Y, Satoh Y, Masuda N.

Oncology. 2017;92(5):283-290. doi: 10.1159/000458412. Epub 2017 Feb 22.

PMID:
28222447
15.

Impact of EGFR-Tyrosine Kinase Inhibitors on Postoperative Recurrent Non-Small-Cell Lung Cancer Harboring EGFR Mutations.

Igawa S, Ryuge S, Ichinoe M, Nakashima H, Otani S, Nakahara Y, Fukui T, Sasaki J, Kubota M, Katagiri M, Murakumo Y, Satoh Y, Sato Y, Masuda N.

Oncol Res Treat. 2017;40(1-2):7-13. doi: 10.1159/000455147. Epub 2017 Jan 25.

16.

CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.

Yokoyama M, Ichinoe M, Okina S, Sakurai Y, Nakada N, Yanagisawa N, Jiang SX, Numata Y, Umezawa A, Miyazaki K, Higashihara M, Murakumo Y.

Int J Hematol. 2017 May;105(5):614-622. doi: 10.1007/s12185-016-2173-1. Epub 2016 Dec 28.

PMID:
28032275
17.

Suppression of skin tumorigenesis in CD109-deficient mice.

Sunagawa M, Mii S, Enomoto A, Kato T, Murakumo Y, Shiraki Y, Asai N, Asai M, Nagino M, Takahashi M.

Oncotarget. 2016 Dec 13;7(50):82836-82850. doi: 10.18632/oncotarget.12653.

18.

CD109 is a component of exosome secreted from cultured cells.

Sakakura H, Mii S, Hagiwara S, Kato T, Yamamoto N, Hibi H, Takahashi M, Murakumo Y.

Biochem Biophys Res Commun. 2016 Jan 22;469(4):816-22. doi: 10.1016/j.bbrc.2015.12.063. Epub 2015 Dec 18.

PMID:
26707640
19.

High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab.

Okina S, Yanagisawa N, Yokoyama M, Sakurai Y, Numata Y, Umezawa A, Higashihara M, Murakumo Y.

Int J Hematol. 2015 Dec;102(6):662-9. doi: 10.1007/s12185-015-1880-3. Epub 2015 Oct 8.

PMID:
26449786
20.

L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.

Ichinoe M, Yanagisawa N, Mikami T, Hana K, Nakada N, Endou H, Okayasu I, Murakumo Y.

Pathol Res Pract. 2015 Jul;211(7):533-8. doi: 10.1016/j.prp.2015.03.007. Epub 2015 Apr 7.

PMID:
25908107
21.

L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management.

Yanagisawa N, Satoh T, Hana K, Ichinoe M, Nakada N, Endou H, Okayasu I, Murakumo Y.

Cancer Biomark. 2015;15(4):365-74. doi: 10.3233/CBM-150486.

PMID:
25835180
22.

Diagnostic and prognostic significances of MUC5B and TTF-1 expressions in resected non-small cell lung cancer.

Nagashio R, Ueda J, Ryuge S, Nakashima H, Jiang SX, Kobayashi M, Yanagita K, Katono K, Satoh Y, Masuda N, Murakumo Y, Hachimura K, Sato Y.

Sci Rep. 2015 Mar 3;5:8649. doi: 10.1038/srep08649.

23.

CD109 attenuates TGF-β1 signaling and enhances EGF signaling in SK-MG-1 human glioblastoma cells.

Zhang JM, Murakumo Y, Hagiwara S, Jiang P, Mii S, Kalyoncu E, Saito S, Suzuki C, Sakurai Y, Numata Y, Yamamoto T, Takahashi M.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):252-258. doi: 10.1016/j.bbrc.2015.02.093. Epub 2015 Feb 25.

24.

Regulation of cargo-selective endocytosis by dynamin 2 GTPase-activating protein girdin.

Weng L, Enomoto A, Miyoshi H, Takahashi K, Asai N, Morone N, Jiang P, An J, Kato T, Kuroda K, Watanabe T, Asai M, Ishida-Takagishi M, Murakumo Y, Nakashima H, Kaibuchi K, Takahashi M.

EMBO J. 2014 Sep 17;33(18):2098-112. doi: 10.15252/embj.201488289. Epub 2014 Jul 24.

25.

High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomas.

Yanagisawa N, Hana K, Nakada N, Ichinoe M, Koizumi W, Endou H, Okayasu I, Murakumo Y.

Cancer Med. 2014 Oct;3(5):1246-55. doi: 10.1002/cam4.272. Epub 2014 Jun 2.

26.

TRIM27/MRTF-B-dependent integrin β1 expression defines leading cells in cancer cell collectives.

Kato T, Enomoto A, Watanabe T, Haga H, Ishida S, Kondo Y, Furukawa K, Urano T, Mii S, Weng L, Ishida-Takagishi M, Asai M, Asai N, Kaibuchi K, Murakumo Y, Takahashi M.

Cell Rep. 2014 May 22;7(4):1156-67. doi: 10.1016/j.celrep.2014.03.068. Epub 2014 May 1.

27.

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells.

Niimi K, Murakumo Y, Watanabe N, Kato T, Mii S, Enomoto A, Asai M, Asai N, Yamamoto E, Kajiyama H, Shibata K, Kikkawa F, Takahashi M.

Cancer Sci. 2014 May;105(5):545-52. doi: 10.1111/cas.12390. Epub 2014 Apr 7.

28.

Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.

Sakakura H, Murakumo Y, Mii S, Hagiwara S, Kato T, Asai M, Hoshino A, Yamamoto N, Sobue S, Ichihara M, Ueda M, Takahashi M.

PLoS One. 2014 Jan 6;9(1):e83385. doi: 10.1371/journal.pone.0083385. eCollection 2014.

29.

Association of D2-40 and MMP-1 expression with cyst formation in lung metastatic lesions of cutaneous angiosarcoma on the scalp: immunohistochemical analysis of 23 autopsy cases.

Masuzawa M, Mikami T, Numata Y, Tokuyama W, Masuzawa M, Murakumo Y, Okayasu I, Katsuoka K.

Hum Pathol. 2013 Dec;44(12):2751-9. doi: 10.1016/j.humpath.2013.07.022. Epub 2013 Oct 11.

PMID:
24125743
30.

Small gastrointestinal stromal tumor in the stomach: identification of precursor for clinical gastrointestinal stromal tumor using c-kit and α-smooth muscle actin expression.

Mikami T, Nemoto Y, Numata Y, Hana K, Nakada N, Ichinoe M, Murakumo Y, Okayasu I.

Hum Pathol. 2013 Dec;44(12):2628-35. doi: 10.1016/j.humpath.2013.07.020. Epub 2013 Oct 10.

PMID:
24119563
31.

Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.

Miyachi H, Mii S, Enomoto A, Murakumo Y, Kato T, Asai N, Komori K, Takahashi M.

J Vasc Surg. 2014 Aug;60(2):479-489.e5. doi: 10.1016/j.jvs.2013.06.080. Epub 2013 Aug 12.

32.

The REV7 subunit of DNA polymerase ζ is essential for primordial germ cell maintenance in the mouse.

Watanabe N, Mii S, Asai N, Asai M, Niimi K, Ushida K, Kato T, Enomoto A, Ishii H, Takahashi M, Murakumo Y.

J Biol Chem. 2013 Apr 12;288(15):10459-71. doi: 10.1074/jbc.M112.421966. Epub 2013 Mar 5.

33.

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.

Horio M, Kato T, Mii S, Enomoto A, Asai M, Asai N, Murakumo Y, Shibata K, Kikkawa F, Takahashi M.

Cancer Med. 2012 Oct;1(2):218-29. doi: 10.1002/cam4.32. Epub 2012 Sep 13.

34.

Similar phenotypes of Girdin germ-line and conditional knockout mice indicate a crucial role for Girdin in the nestin lineage.

Asai M, Asai N, Murata A, Yokota H, Ohmori K, Mii S, Enomoto A, Murakumo Y, Takahashi M.

Biochem Biophys Res Commun. 2012 Oct 5;426(4):533-8. doi: 10.1016/j.bbrc.2012.08.122. Epub 2012 Sep 4.

PMID:
22974978
35.

Epidermal hyperplasia and appendage abnormalities in mice lacking CD109.

Mii S, Murakumo Y, Asai N, Jijiwa M, Hagiwara S, Kato T, Asai M, Enomoto A, Ushida K, Sobue S, Ichihara M, Takahashi M.

Am J Pathol. 2012 Oct;181(4):1180-9. doi: 10.1016/j.ajpath.2012.06.021. Epub 2012 Jul 27.

PMID:
22846721
36.

Exposure to 1-bromopropane induces microglial changes and oxidative stress in the rat cerebellum.

Subramanian K, Mohideen SS, Suzumura A, Asai N, Murakumo Y, Takahashi M, Jin S, Zhang L, Huang Z, Ichihara S, Kitoh J, Ichihara G.

Toxicology. 2012 Dec 8;302(1):18-24. doi: 10.1016/j.tox.2012.07.006. Epub 2012 Jul 21.

PMID:
22824114
37.

The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility.

Ishida-Takagishi M, Enomoto A, Asai N, Ushida K, Watanabe T, Hashimoto T, Kato T, Weng L, Matsumoto S, Asai M, Murakumo Y, Kaibuchi K, Kikuchi A, Takahashi M.

Nat Commun. 2012 May 29;3:859. doi: 10.1038/ncomms1861.

PMID:
22643886
38.

Involvement of Girdin in the determination of cell polarity during cell migration.

Ohara K, Enomoto A, Kato T, Hashimoto T, Isotani-Sakakibara M, Asai N, Ishida-Takagishi M, Weng L, Nakayama M, Watanabe T, Kato K, Kaibuchi K, Murakumo Y, Hirooka Y, Goto H, Takahashi M.

PLoS One. 2012;7(5):e36681. doi: 10.1371/journal.pone.0036681. Epub 2012 May 4.

39.

RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations.

Iwakoshi A, Murakumo Y, Kato T, Kitamura A, Mii S, Saito S, Yatabe Y, Takahashi M.

Pathol Int. 2012 May;62(5):324-30. doi: 10.1111/j.1440-1827.2012.02797.x. Epub 2012 Mar 27.

PMID:
22524660
40.

Molecular chaperone Hsp90 regulates REV1-mediated mutagenesis.

Pozo FM, Oda T, Sekimoto T, Murakumo Y, Masutani C, Hanaoka F, Yamashita T.

Mol Cell Biol. 2011 Aug;31(16):3396-409. doi: 10.1128/MCB.05117-11. Epub 2011 Jun 20.

41.

Girdin is an intrinsic regulator of neuroblast chain migration in the rostral migratory stream of the postnatal brain.

Wang Y, Kaneko N, Asai N, Enomoto A, Isotani-Sakakibara M, Kato T, Asai M, Murakumo Y, Ota H, Hikita T, Namba T, Kuroda K, Kaibuchi K, Ming GL, Song H, Sawamoto K, Takahashi M.

J Neurosci. 2011 Jun 1;31(22):8109-22. doi: 10.1523/JNEUROSCI.1130-11.2011.

42.

Analysis of glial cell line-derived neurotrophic factor-inducible zinc finger protein 1 expression in human diseased kidney.

Saito S, Murakumo Y, Tsuzuki T, Dambara A, Kato T, Enomoto A, Asai N, Maruyama S, Matsuo S, Takahashi M.

Hum Pathol. 2011 Jun;42(6):848-58. doi: 10.1016/j.humpath.2010.09.015. Epub 2011 Feb 2.

PMID:
21292309
43.

Protective role of Gipie, a Girdin family protein, in endoplasmic reticulum stress responses in endothelial cells.

Matsushita E, Asai N, Enomoto A, Kawamoto Y, Kato T, Mii S, Maeda K, Shibata R, Hattori S, Hagikura M, Takahashi K, Sokabe M, Murakumo Y, Murohara T, Takahashi M.

Mol Biol Cell. 2011 Mar 15;22(6):736-47. doi: 10.1091/mbc.E10-08-0724. Epub 2011 Feb 2.

44.

Loss of Sprouty2 partially rescues renal hypoplasia and stomach hypoganglionosis but not intestinal aganglionosis in Ret Y1062F mutant mice.

Miyamoto R, Jijiwa M, Asai M, Kawai K, Ishida-Takagishi M, Mii S, Asai N, Enomoto A, Murakumo Y, Yoshimura A, Takahashi M.

Dev Biol. 2011 Jan 15;349(2):160-8. doi: 10.1016/j.ydbio.2010.11.002. Epub 2010 Nov 9.

45.

Correlation of pathological grade and tumor stage of urothelial carcinomas with CD109 expression.

Hagikura M, Murakumo Y, Hasegawa M, Jijiwa M, Hagiwara S, Mii S, Hagikura S, Matsukawa Y, Yoshino Y, Hattori R, Wakai K, Nakamura S, Gotoh M, Takahashi M.

Pathol Int. 2010 Nov;60(11):735-43. doi: 10.1111/j.1440-1827.2010.02592.x. Epub 2010 Oct 6.

PMID:
20946523
46.

Analysis of DOK-6 function in downstream signaling of RET in human neuroblastoma cells.

Kurotsuchi A, Murakumo Y, Jijiwa M, Kurokawa K, Itoh Y, Kodama Y, Kato T, Enomoto A, Asai N, Terasaki H, Takahashi M.

Cancer Sci. 2010 May;101(5):1147-55. doi: 10.1111/j.1349-7006.2010.01520.x. Epub 2010 Feb 3.

47.

Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1.

Hara K, Hashimoto H, Murakumo Y, Kobayashi S, Kogame T, Unzai S, Akashi S, Takeda S, Shimizu T, Sato M.

J Biol Chem. 2010 Apr 16;285(16):12299-307. doi: 10.1074/jbc.M109.092403. Epub 2010 Feb 17.

48.

The molecular chaperone Hsp90 regulates accumulation of DNA polymerase eta at replication stalling sites in UV-irradiated cells.

Sekimoto T, Oda T, Pozo FM, Murakumo Y, Masutani C, Hanaoka F, Yamashita T.

Mol Cell. 2010 Jan 15;37(1):79-89. doi: 10.1016/j.molcel.2009.12.015. Epub 2010 Jan 14.

49.

Processing of CD109 by furin and its role in the regulation of TGF-beta signaling.

Hagiwara S, Murakumo Y, Mii S, Shigetomi T, Yamamoto N, Furue H, Ueda M, Takahashi M.

Oncogene. 2010 Apr 15;29(15):2181-91. doi: 10.1038/onc.2009.506. Epub 2010 Jan 25.

PMID:
20101215
50.

Overlapping in short motif sequences for binding to human REV7 and MAD2 proteins.

Hanafusa T, Habu T, Tomida J, Ohashi E, Murakumo Y, Ohmori H.

Genes Cells. 2010 Mar;15(3):281-96. doi: 10.1111/j.1365-2443.2009.01380.x. Epub 2010 Jan 19.

Supplemental Content

Loading ...
Support Center